Results 91 to 100 of about 81,968 (115)

Correction: Efficacy of novel endoscopic hemostatic agent for bleeding control and prevention: Results from a prospective, multicenter national registry

Endoscopy International Open
Roberta Maselli, Leonardo Da Rio, Mauro Manno, Paola Soriani, Gianluca Andrisani, Francesco Maria Di Matteo, Carlo Fabbri, Monica Sbrancia, Cecilia Binda, Alba Panarese, Fulvio D'Abramo, Teresa Staiano, Stefano Rizza, Renato Cannizzaro, Stefania Maiero, Vittoria Stigliano, Germana de Nucci, Gianpiero Manes, Marco Sacco, Antonio Facciorusso, Cesare Hassan, Alessandro Repici   +21 more
doaj   +1 more source

Ursolic acid: A promising therapeutic agent for metabolic dysfunction-associated steatotic liver disease via inhibition of SPP1-induced Th17 cell differentiation: Editorial on “Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against metabolic dysfunction-associated steatotic liver disease” [PDF]

Clinical and Molecular Hepatology
So Jung Kim, Jeongeun Hyun
doaj   +1 more source

Macrophage ATG16L1: Potential candidate for metabolic dysfunction-associated steatohepatitis treatment: Editorial on “Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy” [PDF]

Clinical and Molecular Hepatology
Junjie Yu
doaj   +1 more source

X-Tackling the Path to Closure: Post-Endoscopic Submucosal Dissection Defect Resolution Strategies

GE: Portuguese Journal of Gastroenterology
João A. Cunha Neves, Jéssica Chaves, Mário Dinis-Ribeiro, Diogo Libânio   +3 more
doaj   +1 more source

Comments on the article, “Performance of the predictive criteria of the American Society for Gastrointestinal Endoscopy in the diagnosis of choledocholithiasis at a secondary care public hospital in the state of Nuevo León, Mexico”

Revista de Gastroenterología de México (English Edition)
J.K. Crisostomo-Estrada, N.Y. Gonzales-Reyes, Y.I. Ñahui Sullca   +2 more
doaj   +1 more source

ABT-869, a promising multi-targeted tyrosine kinase inhibitor: from bench to bedside [PDF]

Journal of Hematology and Oncology, 2009
Tyrosine Kinase Inhibitors (TKI) have significantly changed the landscape of current cancer therapy. Understanding of mechanisms of aberrant TK signaling and strategies to inhibit TKs in cancer, further promote the development of novel agents. ABT-869, a
Jianbiao Zhou, Boon Cher Goh, Daniel H Albert   +2 more
exaly   +2 more sources

CK-666 and CK-869 differentially inhibit Arp2/3 iso-complexes

EMBO Reports
The inhibitors, CK-666 and CK-869, are widely used to probe the function of Arp2/3 complex mediated actin nucleation in vitro and in cells. However, in mammals, the Arp2/3 complex consists of 8 iso-complexes, as three of its subunits (Arp3, ArpC1, ArpC5)
Luyan Cao, Shaina Huang, Angika Basant   +2 more
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Reexamination of the A.D. 869 Jogan earthquake size from tsunami deposit distribution, simulated flow depth, and velocity

Geophysical Research Letters, 2014
Yuichi Namegaya, Kenji Satake
exaly  

Use of CK-548 and CK-869 as Arp2/3 complex inhibitors directly suppresses microtubule assembly both in vitro and in vivo

Biochemical and Biophysical Research Communications, 2018
Akira Matsuura
exaly  

Phase 2 Trial of Linifanib (ABT-869) in Patients with Advanced Non-small Cell Lung Cancer

Journal of Thoracic Oncology, 2011
Eng-Huat Tan, Ravi Salgia, Benjamin Besse   +2 more
exaly